• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,398.72 789.74
( 1.06%)
Global Indices
Nasdaq
49,714.12 -67.45
(-0.14%)
Dow Jones
7,466.35 44.39
(0.60%)
Hang Seng
62,791.91 -480.20
(-0.76%)
Nikkei 225
10,362.65 37.30
(0.36%)
Forex
USD-INR
95.60 0.47
(0.49%)
EUR-INR
112.29 0.30
(0.26%)
GBP-INR
129.50 0.02
(0.02%)
JPY-INR
0.61 0.00
(0.19%)

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524715
INE044A01036
99.2482659
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SUNPHARMA
100.3
437734.67
EPS(TTM)
Face Value()
Div & Yield %
18.19
1
0.88
 

Elpro International reports consolidated net loss of Rs 91.97 crore in the March 2026 quarter
Apr 29,2026
Net loss of Elpro International reported to Rs 91.97 crore in the quarter ended March 2026 as against net profit of Rs 7.37 crore during the previous quarter ended March 2025. Sales rose 165.37% to Rs 185.44 crore in the quarter ended March 2026 as against Rs 69.88 crore during the previous quarter ended March 2025.

For the full year,net profit rose 32.16% to Rs 87.37 crore in the year ended March 2026 as against Rs 66.11 crore during the previous year ended March 2025. Sales rose 35.34% to Rs 528.14 crore in the year ended March 2026 as against Rs 390.23 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales185.4469.88 165 528.14390.23 35
OPM %-38.2045.25 -29.6820.73 -
PBDT-118.276.02 PL 115.5484.64 37
PBT-122.572.79 PL 100.3974.27 35
NP-91.977.37 PL 87.3766.11 32